Portolan Capital Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-352,257
| Closed | -$11M | – | 137 |
|
|
2025
Q1 | $11M | Buy |
352,257
+8,072
| +2% | +$251K | 0.83% | 43 |
|
|
2024
Q4 | $8.78M | Buy |
344,185
+173,721
| +102% | +$4.43M | 0.59% | 62 |
|
|
2024
Q3 | $4.82M | Buy |
+170,464
| New | +$4.82M | 0.35% | 88 |
|
|
2024
Q2 | – | Sell |
-288,378
| Closed | -$8.76M | – | 131 |
|
|
2024
Q1 | $8.76M | Buy |
288,378
+138,551
| +92% | +$4.21M | 0.67% | 54 |
|
|
2023
Q4 | $4.21M | Buy |
149,827
+71,475
| +91% | +$2.01M | 0.37% | 83 |
|
|
2023
Q3 | $2.13M | Sell |
78,352
-60,139
| -43% | -$1.63M | 0.2% | 107 |
|
|
2023
Q2 | $4.26M | Sell |
138,491
-73,962
| -35% | -$2.27M | 0.38% | 77 |
|
|
2023
Q1 | $7.65M | Buy |
+212,453
| New | +$7.65M | 0.73% | 47 |
|